Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,932 | -3,177 | -3,528 | -2,729 | -1,753 |
| Accounts receivable | 1,000 | 1,000 | -444 | 456 | 31 |
| Accounts payable and accrued liabilities | 1,089 | -51 | 118 | 90 | 72 |
| Other Working Capital | 2,215 | 1,943 | -227 | 648 | 54 |
| Other Operating Activity | -1,980 | -891 | 767 | -200 | 125 |
| Operating Cash Flow | $-2,608 | $-1,176 | $-3,314 | $-1,735 | $-1,471 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -66 | N/A | N/A | N/A |
| Investing Cash Flow | $-66 | $-66 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 825 | 825 | 3,322 | 3,071 | 1,245 |
| Financing Cash Flow | $825 | $825 | $3,322 | $3,071 | $1,245 |
| Beginning Cash Position | 3,240 | 3,240 | 3,232 | 3,232 | 3,232 |
| End Cash Position | 1,391 | 2,823 | 3,240 | 4,568 | 3,006 |
| Net Cash Flow | $-1,849 | $-417 | $8 | $1,336 | $-226 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,608 | -1,176 | -3,314 | -1,735 | -1,471 |
| Capital Expenditure | -66 | -66 | N/A | N/A | N/A |
| Free Cash Flow | -2,674 | -1,242 | -3,314 | -1,735 | -1,471 |